NICE Decision On Arthritis Opens Door For Biosimilars In England
UK Recommends Treating Moderate Rheumatoid Arthritis With Three Biologic Molecules
Certain biologics were found to be a cost-effective use of NHS resources for treating moderate rheumatoid arthritis 
